Very Positive29 Nov 2019 19:24
“ Dr Markku Jalkanen, CEO of Faron, said: "We are very pleased to receive this IND approval from the FDA, marking another milestone in the developmet of Clevegen. This approval will allow us to expand MATINS into the US using the same protocol both in Europe and in the US, accelerating our understanding of this novel precision medicine in cancer patients who are refractory to all other treatment options and streamlining the regulatory processes. With the US IND now approved, in due course, we plan to file applications for Breakthrough status in the US and Prime status in Europe, further facilitating regulatory interactions during the development of Clevegen."
As mentioned by other poster here about the the plan to file applications for breakthrough status in usa and prime status in Europe must point to-how confident FARN of their blockbuster products to achieve these approvals which in itself should push the sp much much higher when these filings are approved..
Must buy on volatility dips....as the more you look into it the more positive it appears.
I am pleased that I.leveraged up from 68p...105p , then 157 p last week..
I go a long with huge positivity by many posters here and far from ramping ,
These are facts.